Ivo Teneng
Hematology & Oncology · Bethesda, MDNPI 1548768450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $938, 3.3 times the $282 reported in 2022. That places this record below the midpoint for hematology & oncology clinicians in MD, where the typical reported total is $2,111.
Across 90 payments — averaging $28.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$345
- AbbVie$342
- Sobi, Inc$210
- Karyopharm Therapeutics Inc.$170
- Bristol Myers Squibb$130
- Incyte Corporation$127
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,527100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 7 | $345 |
| AbbVie | 10 | $342 |
| Sobi, Inc | 4 | $210 |
| Karyopharm Therapeutics Inc. | 7 | $170 |
| Bristol Myers Squibb | 5 | $130 |
| Incyte Corporation | 6 | $127 |
| Gilead | 4 | $122 |
| Exelixis Inc. | 4 | $108 |
| AstraZeneca(2 entities) | 5 | $97 |
| Mirati Therapeutics, Inc. | 3 | $76 |
| Morphosys, US Inc. | 3 | $68 |
| Genmab U.S., Inc. | 2 | $66 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $62 |
| Daiichi Sankyo Inc. | 3 | $49 |
| Coherus Oncology, Inc. | 2 | $46 |
| ADC Therapeutics America, Inc. | 2 | $46 |
| Recordati_rare_diseases_inc. | 2 | $45 |
| G1 Therapeutics, Inc. | 2 | $44 |
| Amgen | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Geron Corporation | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $26 |
| GSK | 1 | $25 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $24 |
| Immunogen, Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Beone Medicines USA, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $19 |
| BTG International Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| CTI Biopharma Corp. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,527 in reported general payments places this provider in the 50th percentile of 242 hematology & oncology providers in Maryland.
Other hematology & oncology in Bethesda
- Ralph BocciaBethesda$3.1M
- Sandra SwainBethesda$1M
- Chitra RajagopalBethesda$89K
- Susan LeitmanBethesda$44K
- Giuseppe GiacconeBethesda$32K
- Phillip ScheinbergBethesda$27K
- Steven PavleticBethesda$13K
- Kashif AliSilver Spring$987K
- Ani BalmanoukianBaltimore$842K
- Benjamin LevyBaltimore$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.